A study of the expression of four chemoresistance-related genes in human primary and metastatic brain tumours.

[1]  R. Hruban,et al.  Multidrug resistance gene (MDR1) expression in human brain tumors. , 1991, Journal of neurosurgery.

[2]  P M Black,et al.  Brain tumors. Part 1. , 1991, The New England journal of medicine.

[3]  E. Tani,et al.  Expression of P-glycoprotein in human glioma cell lines and surgical glioma specimens. , 1991, Journal of neurosurgery.

[4]  C. Wolf,et al.  The role of glutathione-dependent enzymes in drug resistance. , 1991, Pharmacology & therapeutics.

[5]  A. Hara,et al.  Immunohistochemical demonstration of the placental form of glutathione S‐transferase, a detoxifying enzyme in human gliomas , 1990, Cancer.

[6]  M. Melamed,et al.  Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues. , 1990, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[7]  I. Pastan,et al.  Genetic basis of multidrug resistance of tumor cells , 1990, Journal of bioenergetics and biomembranes.

[8]  B. Ketterer,et al.  The role of glutathione and glutathione transferases in chemical carcinogenesis. , 1990, Critical reviews in biochemistry and molecular biology.

[9]  J. Furuyama,et al.  Amplification and expression of a multidrug resistance gene in human glioma cell lines. , 1990, Journal of neurosurgery.

[10]  W. T. Beck.  Unknotting the complexities of multidrug resistance: the involvement of DNA topoisomerases in drug action and resistance. , 1989, Journal of the National Cancer Institute.

[11]  B. Stewart,et al.  Resistance to drugs associated with the multidrug resistance phenotype following selection with high-concentration methotrexate. , 1989, Journal of the National Cancer Institute.

[12]  H. Wieand,et al.  Expression of anionic glutathione-S-transferase and P-glycoprotein genes in human tissues and tumors. , 1989, Cancer research.

[13]  K. Cowan,et al.  Differential increases in glutathione S-transferase activities in a range of multidrug-resistant human tumor cell lines. , 1989, Cancer communications.

[14]  R. Hertzberg,et al.  Camptothecin-resistant mutants of Chinese hamster ovary cells containing a resistant form of topoisomerase I. , 1988, Cancer research.

[15]  M. Abramovitz,et al.  Characterization and Localization of Glutathione‐S‐Transferases in Rat Brain and Binding of Hormones, Neurotransmitters, and Drugs , 1988, Journal of neurochemistry.

[16]  N. Greig.  Optimizing drug delivery to brain tumors. , 1987, Cancer treatment reviews.

[17]  I. Pastan,et al.  Expression of a multidrug-resistance gene in human tumors and tissues. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[18]  D. Sullivan,et al.  Proliferation dependence of topoisomerase II mediated drug action. , 1986, Biochemistry.

[19]  Hill Bt.  In vitro human tumour model systems for investigating drug resistance. , 1986 .

[20]  M. Berger,et al.  Repair of O6-(2-chloroethyl)guanine mediates the biological effects of chloroethylnitrosoureas. , 1985, Environmental health perspectives.

[21]  Wang Al,et al.  Increased glutathione-S-transferase activity in a cell line with acquired resistance to nitrogen mustards. , 1985 .

[22]  G. Riou,et al.  A type-II DNA topoisomerase and a catenating protein from the transplantable VX2 carcinoma. , 1985, European journal of biochemistry.

[23]  V. Devita,et al.  Cancer : Principles and Practice of Oncology , 1982 .

[24]  W. Rutter,et al.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. , 1979, Biochemistry.

[25]  Goldovskiĭ Am.  Biochemistry and darwinism. Biochemistry and solution of problems of the evolution theory , 1960 .